Question 1 · Hard
A public health laboratory screens 20,000 people for an infection with a prevalence of 0.5%. The screening immunoassay has a sensitivity of 99% and a specificity of 99%. Every reactive screen is then tested with a supplemental assay that has a sensitivity of 98% and a specificity of 99.5%; assume that the two tests make their errors independently. A clinician asks how reliable a reactive result is. The positive predictive values of a reactive screen alone, and of a result reactive on both tests, are:
- AAbout 99% and about 99%
- BAbout 67% and about 99%
- CAbout 33% and about 99%
- DAbout 33% and about 33%
Show answerHide answer
Answer: C · About 33% and about 99%
Of 20,000 people, 100 are infected and 19,900 are not. The screen detects 99 true positives and gives 1% of 19,900, or 199, false positives, so its PPV is 99 ÷ 298 = about 33%, even though its sensitivity and specificity are both 99%. The supplemental test confirms 98% of the true positives (about 97) but only 0.5% of the false positives (about 1), so the PPV of a double-reactive result is about 97 ÷ 98 = 99%. Testing in series raises specificity and PPV at a small cost in sensitivity, which is why low-prevalence screening programs confirm reactive screens before reporting them.
- A: 99% is the screen's sensitivity and specificity, not its predictive value at a prevalence of 0.5%.
- B: About 67% is the share of reactive screens that are false positives, not the PPV.
- D: The supplemental test removes nearly all false positives, so the PPV of a double-reactive result rises.